ORLANDO, Fla., Oct. 14 Dr. Eliane Gluckman, recognized asa pioneer and leader in the field of cord blood stem cell transplantation, hasjoined the team at CORD:USE Cord Blood Bank. "We are honored to have such anaccomplished physician as Dr. Gluckman join our team of highly esteemedphysicians and scientists at CORD:USE," says Edward Guindi M.D., President andCEO of CORD:USE.
Dr. Gluckman is internationally recognized as the pioneering physician whoperformed the world's first successful cord blood transplant (sibling donor)in 1988. In fact, leaders from the international cord blood community will bemeeting in Mandelieu, France, for a cord blood conference this week, onOctober 16-19, to celebrate the 20th anniversary of that first cord bloodtransplantation by Dr. Gluckman. CORD:USE team members, Dr. Broxmeyer and Dr.Kurtzberg, also played significant roles in this historic transplant. Theconference will also focus on the Biology and Clinical Applications of CordBlood Cells.
Dr. Gluckman is Professor of Hematology at the University of Paris VII.She is the head of the International Registry on Cord Blood Transplantation,Eurocord, at the Hospital Saint Louis APHP and President of the EuropeanSchool of Hematology. Dr. Gluckman is a founding member and former Presidentof the European Group of Bone Marrow Transplantation (EBMT). During her 30years as a transplanter, Dr. Gluckman has performed over 1,900 bone marrow andcord blood transplants.
"I am very honored to join the team at CORD:USE. I am particularly gladto participate with long time friends at CORD:USE who have initiated anddeveloped the technology and the clinical use of cord blood transplants," saysDr. Gluckman. "The experience and expertise of the team at CORD:USE willcertainly increase the development of cord blood banking, its clinical use andnew research on stem cells for regenerative medicine."
Dr. Gluckman joins other highly-respected pioneers and leaders in thefield of cord blood stem cell transplantation on the CORD:USE team:
-- Dr. Joanne Kurtzberg, Director of the Pediatric Blood and MarrowProgram at Duke University and Medical Director of the CORD:USE Cord BloodBank at Duke. She performed the first successful cord blood transplant froman unrelated donor in 1993 and has since performed 900 umbilical cord bloodtransplants.
-- Dr. Hal Broxmeyer, the current Vice President and President Elect ofthe American Society of Hematology. Broxmeyer is a founder of the field ofcord blood stem cell transplantation and widely recognized as one of theforemost experts in the world in cord blood stem cell science.
-- Dr. John Wagner, an expert in unrelated hematopoietic stem celltransplantation. Dr. Wagner's study of the use of two cord blood units fortransplantation has made it possible for many more adults to benefit from cordblood stem cell transplantation who would have otherwise not been candidatesfor this therapy.
-- Dr. Alan Levine serves as the company's Chief Scientific Officer. Dr.Levine enjoyed a highly successful 25 year career with the National Institutesof Health ("NIH") where he was most recently the Director of the Blood DiseaseProgram of the National Heart, Lung, and Blood Institute of the NIH. In thiscapacity, Dr. Levine was responsible for initiating the bone marrow andumbilical cord blood research programs at the NIH.
-- Dr. Esmail Zanjani, a world-renowned expert in blood stem cell biology,has led the development of the field of in utero stem cell transplantation andgene therapy as a means of curing genetic diseases prior to birth.
About CORD:USE Cord Blood Bank, Inc.
CORD:USE Cord Blood Bank, headquartered in Orlando, Florida is creating alarge, ethnically diverse, high quality inventory of available cord blood stemcell units for the many patients in need of a potentially life-savingtransplant. CORD:USE Cord Blood Bank has entered into agreements withhospitals across the country to provide mothers the option to donate theirbabies' cord blood. CORD:USE makes these cord blood units available totransplanters, throughout the country and around the world, as a criticalcomponent in their patients' treatment. CORD:USE lists all of its units onthe National Marrow Donor Program's Registry. For more information, pleasevisit our website, www.corduse.com .
SOURCE CORD:USE Cord Blood Bank, Inc.